← Back to Search

Terrain Variation for Plantar Fasciitis

N/A

Recruiting

Led By Antony Merendino, DPM

Research Sponsored by University of Florida

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age >18

Pain upon palpation, or insidious pain onset

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 9 weeks

Awards & highlights

No Placebo-Only Group

Summary

This triallooks into how changing terrain can affect foot muscles and how that might affect foot pathologies.

Who is the study for?

This trial is for adults over 18 in Gainesville who either have healthy feet or suffer from plantar fasciitis, experiencing heel pain that hasn't improved with standard treatments like stretching, medication, and supportive insoles for at least 6 months.

What is being tested?

The study investigates how walking on different terrains affects foot muscle strength. It will compare the foot musculature of healthy individuals against those with plantar fasciitis to see if terrain variation influences foot structure and function.

What are the potential side effects?

Since this trial involves non-invasive observation of walking patterns on varied terrains, there are minimal expected side effects. Participants may experience discomfort related to their existing condition during the study.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am older than 18 years.

Select...

I experience pain when touched or have had a gradual onset of pain.

Select...

I am older than 18 years.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 9 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 9 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 9 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Revised Foot Function Index (FFI-R)

Visual Analog Scale (VAS)

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Control CohortExperimental Treatment2 Interventions

Control Cohort: Will utilize the same minimalist shoe and follow the same training schedule as the treatment group, with the modification of training on hardscapes.

Group II: Treatment CohortActive Control2 Interventions

Treatment Cohort: Will utilize a minimalist shoe (Vibram® Fivefingers) and follow the training protocol described below for training on natural terrain.

0 / 3Eligibility criteria met